Alain Jacquet

22PUBLICATIONS
124CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyInnate immunityMicro- and nanosystemsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 12, 2026
New Generation of Allergen Immunotherapy Using Virus-Like Particles: A Comprehensive Review.

Alain Jacquet, Antonia Fettelschoss-Gabriel, Pål Johansen

|Nov 30, 2025
New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report.

Christian Radauer, Gabriele Gadermaier, Richard E Goodman

|Oct 08, 2025
Allergen-Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy.

Scott A Smith, Cosby A Stone, Alain Jacquet

|Oct 25, 2024
Preclinical development of virus-like particle (VLP)-based immunotherapy against house dust mite allergy.

Piyachat Patniboon, Chanatip Thanasarnthungcharoen, Supapich Chanasit

|Feb 08, 2024
Immunotherapeutic effects of specific and nonspecific mRNA-lipid nanoparticles in a mouse model of HDM-induced airway inflammation.

Chanatip Thanasarnthungcharoen, Supapich Chanasit, Laurence Fievez

|Sep 27, 2023
Hypoallergenic chimeric virus-like particles for the development of shrimp tropomyosin allergen Pen m 1-specific blocking antibodies.

Supapich Chanasit, Elecia Johnston, Chanatip Thanasarnthungcharoen

Pageof 4

Frequent Collaborators

3 joint publications

Tadech Boonpiyathad

2 joint publications

Monika Raulf

2 joint publications

Anna Pomés

2 joint publications

Andreas Lopata